Personal Cfo Solutions, LLC Amgen Inc Transaction History

Personal Cfo Solutions, LLC

$704 Million
Q3 2024

A detailed history of Personal Cfo Solutions, LLC transactions in Amgen Inc stock. As of the latest transaction made, Personal Cfo Solutions, LLC holds 3,346 shares of AMGN stock, worth $985,497. This represents 0.15% of its overall portfolio holdings.

Number of Shares

3,346

Previous 3,174 5.42%

Holding current value

$985,497

Previous $991,000 8.78%

% of portfolio

0.15%

Previous 0.16%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$309.38 - $337.38 $53,213 - $58,029	172 Added 5.42%	3,346 $1.08 Million
Q2 2024 Aug 09, 2024	BUY	$262.75 - $319.31 $30,216 - $36,720	115 Added 3.76%	3,174 $991,000
Q1 2024 May 13, 2024	BUY	$268.87 - $324.56 $86,038 - $103,859	320 Added 11.68%	3,059 $869,000
Q4 2023 Feb 13, 2024	SELL	$255.7 - $288.46 $50,372 - $56,826	-197 Reduced 6.71%	2,739 $788,000
Q3 2023 Nov 13, 2023	BUY	$218.65 - $271.46 $32,578 - $40,447	149 Added 5.35%	2,936 $789,000
Q2 2023 Aug 10, 2023	BUY	$214.27 - $253.37 $23,569 - $27,870	110 Added 4.11%	2,787 $618,000
Q1 2023 May 09, 2023	BUY	$225.79 - $275.2 $44,254 - $53,939	196 Added 7.9%	2,677 $647,000
Q4 2022 Feb 14, 2023	BUY	$229.03 - $291.01 $40,538 - $51,508	177 Added 7.68%	2,481 $651,000
Q3 2022 Nov 01, 2022	BUY	$224.46 - $253.15 $13,916 - $15,695	62 Added 2.77%	2,304 $519,000
Q2 2022 Aug 05, 2022	BUY	$230.71 - $256.74 $7,152 - $7,958	31 Added 1.4%	2,242 $546,000
Q1 2022 May 02, 2022	BUY	$219.27 - $242.57 $13,594 - $15,039	62 Added 2.89%	2,211 $535,000
Q4 2021 Feb 11, 2022	BUY	$198.88 - $227.6 $45,742 - $52,348	230 Added 11.99%	2,149 $483,000
Q3 2021 Nov 18, 2021	BUY	$212.27 - $248.7 $849 - $994	4 Added 0.21%	1,919 $408,000
Q2 2021 Jul 22, 2021	BUY	$233.58 - $259.14 $22,657 - $25,136	97 Added 5.34%	1,915 $467,000
Q1 2021 Apr 21, 2021	BUY	$221.91 - $258.6 $11,317 - $13,188	51 Added 2.89%	1,818 $452,000
Q4 2020 Feb 09, 2021	SELL	$216.38 - $257.67 $40,895 - $48,699	-189 Reduced 9.66%	1,767 $406,000
Q3 2020 Nov 02, 2020	BUY	$234.65 - $260.95 $98,787 - $109,859	421 Added 27.43%	1,956 $0
Q2 2020 Aug 03, 2020	SELL	$197.81 - $242.74 $16,022 - $19,661	-81 Reduced 5.01%	1,535 $362,000
Q1 2020 Apr 30, 2020	SELL	$182.24 - $241.7 $86,199 - $114,324	-473 Reduced 22.64%	1,616 $328,000
Q4 2019 Feb 13, 2020	BUY	$189.21 - $243.2 $395,259 - $508,044	2,089 New	2,089 $500,000

Others Institutions Holding AMGN

# of Institutions

3,122

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Personal Cfo Solutions, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Personal Cfo Solutions, LLC with notifications on news.

Account

Personal Cfo Solutions, LLC Amgen Inc Transaction History